Since taking office in January, President Joe Biden has sought to undo several policies that were established during Donald Trump’s administration. This week, the Biden administration announced another reversal of a Trump-era policy that limited healthcare protections for transgender people.
Health and Human Services Secretary Xavier Becerra announced that the Biden administration is undoing a Trump-era policy against transgender people in healthcare. The rollback was finalized by the Trump administration in June 2020. The protection for transgender people was also regulated by Obamacare, which Trump and the Republicans sought to repeal.
“The Supreme Court has made clear that people have a right not to be discriminated against on the basis of sex and receive equal treatment under the law, no matter their gender identity or sexual orientation. That’s why today HHS announced it will act on related reports of discrimination,” Becerra said in a statement.
“Fear of discrimination can lead individuals to forego care, which can have serious negative health consequences. It is the position of the Department of Health and Human Services that everyone - including LGBTQ people - should be able to access health care, free from discrimination or interference, period,” added Becerra.
Becerra also noted the provision in the Affordable Care Act regarding the protections in an interview with CNN Monday. During Trump’s presidency, HHS announced that it would only recognize discrimination according to the “plain meaning of the world ‘sex’ as male or female and as determined by biology.” The Supreme Court would later rule that the existing federal law prohibits job discrimination based on gender identity or sexual orientation.
Previously, Reuters reported that Biden threw his support towards a proposal made by India and South Africa on temporarily waiving IP patents on COVID-19 vaccines to make them more accessible, especially towards developing countries. Biden confirmed his support for the waiver in his comments to the press.
US Trade Representative Katherine Tai also issued a statement furthering the US’ support for temporarily waiving the IP patents, especially at a time of great need. Many Democratic lawmakers have pushed for a temporary waiver, as did many other countries, despite criticism from the pharmaceutical companies.


US Military Eyes 10,000 Troop Surge to Middle East Amid Iran Nuclear Tensions
China Opens Door to Stronger U.S. Trade Ties Amid Rising Tensions
Trump's Signature to Appear on U.S. Currency Starting Summer 2025
Russia-Iran Military Alliance Deepens With Drone Shipments Amid Middle East Tensions
Trump Administration Settles Lawsuit Barring Federal Agencies from Pressuring Social Media Censorship
G7 Summit 2026: South Africa Excluded Amid U.S. Pressure, Kenya Invited Instead
US Accelerates Taiwan Arms Deliveries Amid Rising China Threat
Trump to Visit China in May for High-Stakes Xi Summit Amid Iran War
Maduro Faces Rare Narcoterrorism Charges in U.S. Court
Russia Strikes Kharkiv and Izmail as Cross-Border Drone War Escalates
FEMA Reinstates $1 Billion Disaster Prevention Grant Program After Court Order
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
Iran Demands Lebanon Be Part of Any Ceasefire Deal With Israel and the U.S.
Kristi Noem Ends Western Hemisphere Tour in Diminished Role After DHS Firing
Trump Pauses Iran Strikes as Peace Talks Stall Amid Military Buildup
California Renames Cesar Chavez Day to Farmworkers Day Following Sexual Abuse Allegations
Jay Bhattacharya to Continue Leading CDC as White House Searches for Permanent Director 



